Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Guidelines for Reporting Trial Protocols and Completed Trials Modified Due to the COVID-19 Pandemic and Other Extenuating Circumstances
Authors
Keywords
-
Journal
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
Volume 326, Issue 3, Pages 257
Publisher
American Medical Association (AMA)
Online
2021-06-21
DOI
10.1001/jama.2021.9941
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical practice guidance for hepatology and liver transplant providers during the COVID-19 pandemic: APASL expert panel consensus recommendations
- (2020) George Lau et al. Hepatology International
- Preserving Clinical Trial Integrity During the Coronavirus Pandemic
- (2020) Mary M. McDermott et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Recommendations from national regulatory agencies for ongoing cancer trials during the COVID-19 pandemic
- (2020) Bruno H R de Paula et al. LANCET ONCOLOGY
- A four-step strategy for handling missing outcome data in randomised trials affected by a pandemic
- (2020) Suzie Cro et al. BMC Medical Research Methodology
- Conducting clinical trials in heart failure during (and after) the COVID-19 pandemic: an Expert Consensus Position Paper from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)
- (2020) Stefan D Anker et al. EUROPEAN HEART JOURNAL
- COVID-19 Ethics and Research
- (2020) Karen M. Meagher et al. MAYO CLINIC PROCEEDINGS
- Changes to aspects of ongoing randomised controlled trials with fixed designs
- (2020) Xanthi Coskinas et al. Trials
- Implications for Design and Analyses of Oncology Clinical Trials During the COVID-19 Pandemic
- (2020) Chaya S. Moskowitz et al. JAMA Oncology
- Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19
- (2020) Bruno M. Tomazini et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Small-Volume Tubes to Reduce Anemia and Transfusion (STRATUS): A Pragmatic Stepped Wedge Cluster Randomized Trial
- (2019) Deborah M Siegal et al. BLOOD
- Rational and design of the T-STORHM Study: A prospective randomized trial comparing fresh whole blood to blood components for acutely bleeding trauma patients
- (2019) C. Martinaud et al. TRANSFUSION CLINIQUE ET BIOLOGIQUE
- Efficacy of a Low-Cost, Heat-Stable Oral Rotavirus Vaccine in Niger
- (2017) Sheila Isanaka et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Conservative vs Conventional Oxygen Therapy on Mortality Among Patients in an Intensive Care Unit
- (2016) Massimo Girardis et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- PRESS Peer Review of Electronic Search Strategies: 2015 Guideline Statement
- (2016) Jessie McGowan et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- The Impact of Protocol Amendments on Clinical Trial Performance and Cost
- (2016) Kenneth A. Getz et al. Therapeutic Innovation & Regulatory Science
- Biomedical research: increasing value, reducing waste
- (2014) Malcolm R Macleod et al. LANCET
- SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
- (2013) An-Wen Chan et al. ANNALS OF INTERNAL MEDICINE
- Prediction and prevention of the next pandemic zoonosis
- (2012) Stephen S Morse et al. LANCET
- Celecoxib plus hormone therapy versus hormone therapy alone for hormone-sensitive prostate cancer: first results from the STAMPEDE multiarm, multistage, randomised controlled trial
- (2012) Nicholas D James et al. LANCET ONCOLOGY
- Failure to report protocol violations in clinical trials: a threat to internal validity?
- (2011) Elizabeth A Sweetman et al. Trials
- CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials
- (2011) David Moher et al. International Journal of Surgery
- The use of interim data and Data Monitoring Committee recommendations in randomized controlled trial reports: frequency, implications and potential sources of bias
- (2008) Puvan Tharmanathan et al. BMC Medical Research Methodology
- Early stopping of randomized clinical trials for overt efficacy is problematic
- (2008) Dirk Bassler et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started